|
|
|
Volumn 55, Issue 2, 2005, Pages 395-452
|
|
"Racially-tailored" medicine unraveled.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARDIOVASCULAR AGENT;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
ARTICLE;
CIVIL RIGHTS;
CONGESTIVE HEART FAILURE;
DRUG COMBINATION;
ETHICS;
ETHNOLOGY;
FINANCIAL MANAGEMENT;
GENETICS;
GOVERNMENT;
HEALTH CARE DELIVERY;
HEALTH CARE ORGANIZATION;
HUMAN;
LEGAL ASPECT;
PATIENT RIGHT;
PHARMACOGENETICS;
POLICY;
PROFESSIONAL STANDARD;
RACE;
SOCIAL PSYCHOLOGY;
UNITED STATES;
CARDIOVASCULAR AGENTS;
CIVIL RIGHTS;
CONTINENTAL POPULATION GROUPS;
DELIVERY OF HEALTH CARE;
DRUG COMBINATIONS;
ETHICS COMMITTEES, RESEARCH;
FEDERAL GOVERNMENT;
FINANCING, GOVERNMENT;
GENETIC RESEARCH;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
ORGANIZATIONAL POLICY;
PATIENT RIGHTS;
PHARMACOGENETICS;
PREJUDICE;
STATE GOVERNMENT;
UNITED STATES;
|
|
EID: 33645958307
PISSN: 00031453
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
